• Poster

Cost-effectiveness of Dabigatran Etexilate 150mg for the Prevention of Venous Thromboembolism in Patients Aged Over 75 Years Undergoing Total Hip or Knee Arthroplasty

Citation

Wolowacz, S. E., Roskell, N. S., Plumb, J. M., Clemens, A., Robinson, P., Dolan, G., & Brenkel, I. J. (2009, May). Cost-effectiveness of Dabigatran Etexilate 150mg for the Prevention of Venous Thromboembolism in Patients Aged Over 75 Years Undergoing Total Hip or Knee Arthroplasty. Presented at ISPOR 14th Annual International Meeting, .

Abstract